MELVIN GONZAGA: Open Payments
NPI 1104842566 · LAVALE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$61 in 4 payments from 2 companies in 2025. Trend: 2023 $302 · 2024 $527 · 2025 $61
Food & beverage: $61
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Belbuca, XTAMPZA, RELISTOR.
Industry payments across MD — which companies pay providers there.
